‘The research paves the way for cell therapies to treat liver disease – in other words, growing ‘mini-bile ducts’ in the lab as replacement parts that can be used to restore a patient’s own liver to health – or to repair damaged organ donor livers, so that they can still be used for transplantation.’ University […]
Archives for February 2021
New NPCA short report out on Cambridge Prognostic Groups
The National Prostate Cancer Audit (NPCA) has published a short report on the use of the Cambridge-developed Cambridge Prognostic Groups for non-metastatic prostate cancer and its utility and benefit in better reporting of treatment trends and patterns in the UK. This follows on from a paper jointly published last year. The NPCA will be used […]